Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7175414 | 0.88 | GAA (0.36) | GAA | |
| SCHEMBL2612450 | 0.85 | GAA (0.50) | GAACYP3A4MAPTLMNATP53 | |
| SCHEMBL31247883 | 0.84 | GAA (0.46) | GAACYP3A4MAPTLMNATP53 | |
| SCHEMBL466160 | 0.84 | GAA (0.46) | GAACYP3A4MAPTLMNATP53 | |
| SCHEMBL7156859 | 0.83 | ESR1 (0.36) | CYP3A4ALDH1A1ESR1ESR2MEN1 | |
| SCHEMBL824482 | 0.78 | GAA (0.63) | GAACYP3A4MAPTALDH1A1ESR1 | |
| SCHEMBL11987177 | 0.78 | GAA (0.59) | GAAMAPTALDH1A1 | |
| SCHEMBL2612424 | 0.77 | GAA (0.39) | GAACYP3A4MAPTCYP1A2ALDH1A1 | |
| SCHEMBL25723567 | 0.77 | GAA (0.48) | GAACYP3A4TP53ALDH1A1ESR1 | |
| SCHEMBL2612468 | 0.77 | GAA (0.65) | GAACYP3A4MAPTALDH1A1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6224791-B1 | PHENYLBENZOFURAN-2-ONE WITH PHOSPHITE | DOVER CHEMICAL CORPORATION | 2001-05-01 | — | — | US | claimed |
| WO-1999003915-A1 | LACTONE/PHOSPHITE BLENDS | DOVER CHEMICAL CORPORATION (US) | 1999-01-28 | — | — | WO | claimed |
| US-8142864-B2 | Cellulose ester pellets, cellulose ester film, manufacturing method of cellulose ester film, polarizing plate, and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-8142864-B2 | Cellulose ester pellets, cellulose ester film, manufacturing method of cellulose ester film, polarizing plate, and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20100047480-A1 | CELLULOSE ESTER PELLETS, CELLULOSE ESTER FILM, MANUFACTURING METHOD OF CELLULOSE ESTER FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY | C/O KONICA MINOLTA OPTO, INC. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20100047480-A1 | CELLULOSE ESTER PELLETS, CELLULOSE ESTER FILM, MANUFACTURING METHOD OF CELLULOSE ESTER FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY | C/O KONICA MINOLTA OPTO, INC. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-7470735-B2 | Phenol-free phosphites | DOVER CHEMICAL CORPORATION (US) | 2008-12-30 | — | — | US | disclosed |
| US-7342060-B2 | Process for manufacture of pentaerythritol diphosphites | DOVER CHEMICAL CORPORATION (US) | 2008-03-11 | — | — | US | disclosed |
| WO-2005113665-A2 | PHENOL-FREE PHOSPHITES | DOVER CHEMICAL CORPORATION (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20050131244-A1 | PROCESS FOR MANUFACTURE OF PENTAERYTHRITOL DIPHOSPHITES | DOVER CHEMICAL CORPORATION (US) | 2005-06-16 | — | — | US | disclosed |
| US-20040180999-A1 | PHENOL-FREE PHOSPHITES | DOVER CHEMICAL CORPORATION (US) | 2004-09-16 | — | — | US | disclosed |
| US-6770693-B2 | COMPRISING BIS-(2,4-DICUMYLPHENYL) PENTAERYTHRITOL DIPHOSPHITE AND HINDERED PHENOL ANTIOXIDANTS USEFUL AS STABILIZERS AGAINST THERMOOXIDATIVE DEGRADATION OF POLYMERS DURING MELT PROCESSING | DOVE CHEMICAL CORPORATION | 2004-08-03 | — | — | US | disclosed |
| US-20020040081-A1 | Blends of phosphites and antioxidants | DOVER CHEMICAL | 2002-04-04 | — | — | US | disclosed |
| US-6224791-B1 | PHENYLBENZOFURAN-2-ONE WITH PHOSPHITE | DOVER CHEMICAL CORPORATION | 2001-05-01 | — | — | US | disclosed |
| WO-1999003915-A1 | LACTONE/PHOSPHITE BLENDS | DOVER CHEMICAL CORPORATION (US) | 1999-01-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131244-A1 | PROCESS FOR MANUFACTURE OF PENTAERYTHRITOL DIPHOSPHITES | GNPAT, DCTPP1, DERA | GAA 2344/4885CYP3A4 113/4885MAPT 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.